Latest ATB Therapeutics News & Updates

See the latest news and media coverage for ATB Therapeutics. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
ATB Therapeutics

Biotechnology company developing antibody-based therapies

atbtherapeutics.com
Headquarters
Aye, Belgium
Founded year
2018
Company type
Private company
Number of employees
41–50

Last updated

Latest news about ATB Therapeutics

In short: ATB Therapeutics appointed Mark Throsby CEO to lead its next phase of growth.

Company announcements

ATB Therapeutics

ATB Therapeutics raises €54 million Series A financing

The round is co-led by EQT Life Sciences and MRL Ventures Fund and funds clinical development of oncology and immunology therapies. Mark Throsby joins as Executive Chair.

Unlock all announcements with a

Media coverage

Yahoo Finance

iBio Selected to Produce ATB Therapeutics' Bioengineered Antibody-Toxin Fusion Proteins

BRYAN, Texas, Dec. 01, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) ("iBio" or the "Company"), a biotech innovator and biologics contract development and manufacturing organization...

Unlock all articles with a

Never miss news about ATB Therapeutics

Track ATB Therapeutics and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.